Finance

Lists
EVMN:NYSE
Evommune Inc
US$ ५.७७
-१.८७%
(-०.११) 1D
US$ ५.७७
०.००% (०.००)
After hours
Closed: अक्टोबर १४, १६:००:०२ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EVMN...
Open
US$ ५.७९
High
US$ ५.९६
Low
US$ ५.६४
Mkt. cap
२०.९४ करोड
Avg. vol.
९.०४ लाख
Volume
०.००
52-wk high
US$ ३३.२०
52-wk low
US$ ५.६४
EPS
-US$ २.८९
Shares outstanding
३.६३ करोड
No. of employees
४८
Open
US$ ५.७९
High
US$ ५.९६
Low
US$ ५.६४
Mkt. cap
२०.९४ करोड
Avg. vol.
९.०४ लाख
Volume
०.००
52-wk high
US$ ३३.२०
52-wk low
US$ ५.६४
EPS
-US$ २.८९
Shares outstanding
३.६३ करोड
No. of employees
४८
News stories
From web sources and news partners
MarketBeat
MarketBeat
·
१९ घण्टा पहिले
Evommune (NYSE:EVMN) Stock Bumped Up to "Hold" by UBS Group
About Evommune Inc
CEO-
Employees४८
Founded२०२०
HeadquartersPalo Alto, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 13 analysts giving stock ratings to EVMN in the past 3 months
Strong buy
Buy
10
Hold
3
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for EVMN in the last 3 months.
Highest
Current US$ ५.७७
US$ ३०.०० (+४१९.९३%)
Average
US$ २२.४० (+२८८.२१%)
Lowest
US$ ८.०० (+३८.६५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alice Nettleton
UBS
Hold
Initiated
US$ ८.००
+३८.६%
10/12/2026
Unknown Analyst
UBS
Hold
Initiated
US$ ८.००
+३८.६%
10/11/2026
Mitchell Kapoor
H.C. Wainwright
Hold
Reiterated
-
-
10/05/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Maintained
-
-
09/17/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
US$ २३.००
+२९८.६%
09/09/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
US$ ३०.००
+४१९.९%
09/09/2026
Serge Belanger
Needham
Buy
Maintained
US$ २८.००
+३८५.३%
09/09/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
US$ २२.००
+२८१.३%
09/10/2026
Martin Auster
Raymond James
Buy
Maintained
US$ १८.००
+२१२%
09/09/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
US$ २६.००
+३५०.६%
09/09/2026
Brian Abrahams
RBC Capital
Buy
Maintained
US$ २१.००
+२६४%
09/08/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
09/09/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
US$ २२.००
+२८१.३%
08/10/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
US$ २६.००
+३५०.६%
08/10/2026
Last report
२०२६ अगस्ट ६
Fiscal period
Q2 2026
-US$ ०.८९ / -US$ ०.६७
-३२.८४%miss
Revenue / Est. (USD)
- / ११.४३ लाख
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.०० करोड
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१.९६ करोड
२.०४ करोड
१.७३ करोड
२.६४ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३६.८९ लाख
९३.१३ लाख
६६.३५ लाख
८४.८३ लाख
Operating expense
२.३३ करोड
२.९७ करोड
२.४० करोड
३.४९ करोड
Total operating expenses
२.३३ करोड
२.९७ करोड
२.४० करोड
३.४९ करोड
Operating income
-१.३३ करोड
-२.९७ करोड
-२.४० करोड
-३.४९ करोड
Other non operating income
-९.०० हजार
-
-४.०० हजार
-२.०० हजार
EBT including unusual items
-१.२५ करोड
-२.८३ करोड
-२.१७ करोड
-३.२२ करोड
EBT excluding unusual items
-१.२५ करोड
-२.८३ करोड
-२.१७ करोड
-३.२२ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१.२५ करोड
-२.८३ करोड
-२.१७ करोड
-३.२२ करोड
Net profit margin
-१२४.७५%
-
-
-
Earnings per share
-८.०७
-१.४३
-०.६४
-०.८९
Interest and investment income
८.६२ लाख
१४.४३ लाख
२२.८४ लाख
२६.५१ लाख
Interest expense
-
-
-
-
Net interest expenses
८.६२ लाख
१४.४३ लाख
२२.८४ लाख
२६.५१ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.३० करोड
-२.९४ करोड
-२.३६ करोड
-३.४३ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू